| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 32,423 | 34,710 | 38,065 | 35,141 | | Cost of Revenue | (14,763) | 13,032 | 34,806 | 33,000 | | | Gross Profit | 47,186 | 21,678 | 3,259 | 2,141 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,426 | 19,327 | 2,348 | 2,667 | | Non Recurring |
-
|
-
|
-
| 421 | | Others | 1,636 | 3,325 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,130) | (974) | 911 | (947) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 13 | 20 | 15 | 9 | | Earnings Before Interest And Taxes | (2,117) | (954) | 926 | (938) | | Interest Expense | 491 | 477 | 479 | 435 | | Income Before Tax | (2,608) | (1,431) | 447 | (1,373) | | Income Tax Expense | (1,289) | (635) | (5) | (674) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,319) | (796) | 452 | (699) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,319) | (796) | 452 | (699) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,319) | ($796) | $452 | ($699) |
|
0.51% Nasdaq 
Income Statement
